NEW
YORK, July 17, 2024 /PRNewswire/ -- The global
direct to consumer laboratory testing market size is estimated to
grow by USD 9.70 billion from
2023-2027, according to Technavio. The market is estimated to grow
at a CAGR of 31.59% during the forecast period.
Convenience and accessibility of DTC laboratory
testing is driving market growth, with a trend
towards increased internet penetration fuels market growth.
However, trust and privacy concerns poses a challenge.
Key market players include 23andMe Holding Co., Any Lab Test Now
Inc., Color Health Inc, DecodeME Partnership, Direct Laboratory
Services LLC, EasyDNA, Everlywell Inc., Genesis Healthcare Co.,
International Biosciences, Konica Minolta Inc., Laboratory Corp. Of
America Holdings, LetsGetChecked, MyMedLab Inc., Myriad Genetics
Inc., Quest Diagnostics Inc., Sonora Quest Laboratories, Ulta Lab
Tests LLC, VERITAS INTERCONTINENTAL, Walk In Lab LLC., and
WellnessFX.
![Technavio has announced its latest market research report titled Global Direct to Consumer Laboratory Testing Market 2023-2027 Technavio has announced its latest market research report titled Global Direct to Consumer Laboratory Testing Market 2023-2027](https://mma.prnewswire.com/media/2462360/Technavio_Global_Direct_to_Consumer_Laboratory_Testing_Market_2023_2027.jpg)
Get a detailed analysis on regions, market
segments, customer landscape, and companies- View the
snapshot of this report
Direct To Consumer
Laboratory Testing Market Scope
|
Report
Coverage
|
Details
|
Base year
|
2022
|
Historic
period
|
2017 - 2021
|
Forecast
period
|
2023-2027
|
Growth momentum &
CAGR
|
Accelerate at a CAGR of
31.59%
|
Market growth
2023-2027
|
USD 9703.47
million
|
Market
structure
|
Fragmented
|
YoY growth 2022-2023
(%)
|
28.62
|
Regional
analysis
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Performing market
contribution
|
North America at
39%
|
Key
countries
|
US, UK, Germany, China,
and Japan
|
Key companies
profiled
|
23andMe Holding Co.,
Any Lab Test Now Inc., Color Health Inc, DecodeME Partnership,
Direct Laboratory Services LLC, EasyDNA, Everlywell Inc., Genesis
Healthcare Co., International Biosciences, Konica Minolta Inc.,
Laboratory Corp. Of America Holdings, LetsGetChecked, MyMedLab
Inc., Myriad Genetics Inc., Quest Diagnostics Inc., Sonora Quest
Laboratories, Ulta Lab Tests LLC, VERITAS INTERCONTINENTAL, Walk In
Lab LLC., and WellnessFX
|
Market Driver
The rise of the Internet has made healthcare services more
accessible to individuals through Direct-to-Consumer (DTC)
laboratory testing. Consumers can now browse and order tests
online, make payments, and schedule sample collections from home.
This convenience has attracted a large customer base seeking
hassle-free testing experiences. The Internet also allows consumers
to compare DTC laboratory testing providers, read reviews, and
evaluate services, leading to informed choices and increased
demand. DTC laboratory testing companies use digital marketing
strategies, such as online ads and social media campaigns, to reach
a broader audience and increase awareness of their services. This
growing awareness and demand will fuel the expansion of the global
DTC laboratory testing market during the forecast period.
The Direct-to-Consumer (DTC) Laboratory Testing market is
experiencing significant growth, particularly in the areas of In
vitro diagnostics, with a focus on Molecular tests and
Immunological tests for infectious diseases like Viral surface
antigens. Rapid tests for Contagious diseases and Genetic tests are
also trending. DTC testing now includes Lifestyle associated
diseases, Saliva sample tests for Glucose and Cholesterol, and
Blood, Urine, and Saliva tests for CBC, Diabetes testing, TSH
testing, and more. DTC labs serve Hospitals, Clinics, Specialty
labs, and Diagnostic centers, as well as Healthcare providers.
Ancestry and genealogy testing, Elderly population testing, and
Personalized medicines are also part of this market. Sample
integrity, Test portfolios, Telehealth, DTC pharmacogenomic
testing, Security and privacy, Professional medical counseling, and
Predictive testing are key considerations. Public-private
partnerships ensure Early disease detection and accessibility. DTC
laboratory testing is a crucial component of Personal health
management.
Discover 360° analysis of this market. For
complete information, schedule your consultation - Book
Here!
Market Challenges
- The Direct to Consumer (DTC) laboratory testing market relies
heavily on consumer trust. Companies must ensure that personal
healthcare information is handled securely and comply with privacy
regulations. Maintaining data privacy, implementing robust security
measures, and transparently communicating privacy practices are
ongoing challenges. DTC laboratory testing providers collect and
store vast amounts of sensitive data, including genetic
information, test results, and medical histories. Data breaches and
unauthorized access can result in severe consequences, such as
identity theft and insurance discrimination. These factors may
hinder the growth of the global DTC laboratory testing market
during the forecast period.
- The Direct-to-Consumer (DTC) laboratory testing market is
experiencing significant growth due to increasing consumer interest
in personal health management. However, several challenges persist.
Healthcare providers express concerns over sample integrity and the
validity of results from non-clinical laboratories. DTC offerings
in ancestry and genealogy testing, as well as DTC pharmacogenomic
testing, require careful consideration of security and privacy. The
elderly population presents unique challenges due to complex test
portfolios and potential complications. Telehealth and predictive
testing, including genome sequencing for chronic diseases like
cancer, diabetes, heart disease, and osteoporosis, require
professional medical counseling. Laboratory professionals must
ensure test accuracy, particularly in areas like chemistry panels,
complete blood count, pregnancy tests, diabetes screening, blood
typing, and screening tests using polymermerase chain reaction.
Marketing campaigns and advertisements must clearly communicate
genetic predisposition, lineage, mortality, and morbidity risks.
Pharmacies and physicians play a crucial role in prescription
management and preventive technologies for chronic disease
management. DTC lab testing must navigate regulatory requirements
and ensure patient privacy and security.
For more insights on driver and
challenges - Request a sample report!
Segment Overview
This direct to consumer laboratory testing market report
extensively covers market segmentation by
- Type
- 1.1 Blood
- 1.2 Urine
- 1.3 Saliva
- 1.4 Others
- Application
- 2.1 Routine clinical testing
- 2.2 Diabetes testing
- 2.3 Genetic testing
- 2.4 Thyroid stimulating hormone testing
- 2.5 Others
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Blood- The global direct to consumer (DTC)
laboratory testing market's largest segment in 2022 was blood
testing. Individuals can easily order blood tests online or through
mobile apps, eliminating the need for hospital or laboratory
appointments. DTC blood testing empowers people to regularly
monitor their health, identify potential risks, and manage
deficiencies. It covers various health parameters such as
cholesterol levels, vitamin deficiencies, hormone levels, genetic
predispositions, and more. DTC blood testing offers individuals
control over their health information, ensuring privacy and
confidentiality. Some prefer bypassing traditional healthcare
providers for this reason. The convenience and direct access to
testing services have fueled the demand for DTC blood testing,
making it a growing segment in the market.
For more information on market segmentation with geographical
analysis including forecast (2023-2027) and historic data
(2017-2021) - Download a Sample Report
Learn and explore more about Technavio's in-depth research
reports
The market for laboratory analytical instruments and consumables
is driven by increasing demand for efficient testing and research
tools across pharmaceutical, biotechnology, and academic sectors
globally. The clinical laboratory services market is expanding due
to rising healthcare expenditure, increasing prevalence of chronic
diseases, and advancements in diagnostic technologies, offering
vital diagnostic insights crucial for patient care and disease
management. LIMS facilitate efficient data management in
laboratories, enhancing workflow automation, sample tracking, and
regulatory compliance. The market growth is fueled by the need for
integrated systems to streamline laboratory operations and ensure
data integrity.
Research Analysis
The Direct to Consumer (DTC) Laboratory Testing market refers to
the sale of laboratory tests directly to consumers without the
involvement of healthcare providers. DTC lab testing allows
individuals to access various types of tests, including ancestry
and genealogy testing, medical disorders screening, and personal
health management, using samples collected at home. The process
involves sending samples to laboratories for analysis, which can
provide results through digital platforms or telehealth services.
DTC lab testing offers convenience and affordability, especially
for elderly populations and those with limited access to
healthcare. Laboratory professionals conduct tests using advanced
techniques such as chemistry panels, complete blood count,
pregnancy tests, diabetes screening, blood typing, and more complex
screening tests like Polymerase chain reaction (PCR), in vitro
diagnostics, molecular tests, immunological tests, viral surface
antigens, and others. Sample integrity is crucial to ensure
accurate results, and test portfolios continue to expand with new
offerings like DTC pharmacogenomic testing. Security and privacy
are essential considerations to maintain confidentiality and
protect sensitive health information.
Market Research Overview
Direct to Consumer (DTC) laboratory testing is a rapidly growing
segment in healthcare, allowing individuals to order and manage
their own lab tests online without the need for a healthcare
provider's order. DTC testing includes various types of tests, such
as ancestry and genealogy testing, personal health management, and
DTC pharmacogenomic testing. The elderly population is a
significant market for DTC testing due to the increasing need for
chronic disease management and early disease detection. Sample
integrity is crucial for accurate test results, and DTC
laboratories use advanced technologies like Polymerase chain
reaction (PCR), in vitro diagnostics, and molecular tests to ensure
sample quality. Telehealth and user-friendly diagnostics enable
remote testing and results access, making DTC testing more
accessible. DTC lab testing covers a wide range of tests, including
chemistry panels, complete blood count (CBC), pregnancy tests,
diabetes screening, blood typing, and screening tests for
infectious diseases, contagious diseases, and lifestyle-associated
diseases. Security and privacy are essential considerations for DTC
testing companies, and professional medical counseling and
predictive testing are often provided to help individuals
understand their results and manage their health. Chronic diseases,
such as cancer, diabetes, heart disease, and osteoporosis, are
significant targets for DTC testing. Family health history, genetic
predisposition, and lineage testing are also popular, with
implications for mortality and morbidity. DTC testing is available
through various channels, including laboratories, pharmacies, and
diagnostic centers, and marketing campaigns and advertisements play
a crucial role in reaching consumers. DTC lab testing involves
various stakeholders, including laboratories, clinical
laboratories, hospitals, clinics, specialty labs, diagnostic
centers, and public-private partnerships. Laboratory professionals
process samples using various tests, such as blood, urine, and
saliva tests, and reference laboratories provide specialized
testing services. Personalized medicines and preventive
technologies are emerging trends in DTC testing, offering
opportunities for early disease detection and chronic disease
management.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- Type
-
- Blood
- Urine
- Saliva
- Others
- Application
-
- Routine Clinical Testing
- Diabetes Testing
- Genetic Testing
- Thyroid Stimulating Hormone Testing
- Others
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/direct-to-consumer-laboratory-testing-market-size-is-set-to-grow-by-usd-9-70-billion-from-2023-2027--convenience-and-accessibility-of-dtc-laboratory-testing-boost-the-market-technavio-302198296.html
SOURCE Technavio